MetaCap

Vistagen Therapeutics Inc. Company Profile

NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.2462-0.0009 (-0.36%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 0.2462 0.00%

Vistagen Therapeutics at a glance

Vistagen Therapeutics Inc. (NASDAQ: VTGN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. At a market capitalization of $11.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001411685, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
Vistagen Therapeutics Inc.
Ticker
NASDAQ: VTGN
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
United States
Market cap
$10.97M
SEC CIK
0001411685

Companies similar to Vistagen Therapeutics

VTGN peer companies
CompanyPrice% ChgMarket capCompare
BLRXBioLineRx Ltd. ADR2.21+0.23%$11.00Mvs VTGN
BIVIBioVie Inc. Class A1.28-8.57%$11.11Mvs VTGN
GTBPGT Biopharma Inc.5.96-3.87%$10.75Mvs VTGN
KPRXKiora Pharmaceuticals Inc.2.530.00%$11.19Mvs VTGN
GDTCCytoMed Therapeutics Limited0.9449-3.56%$11.28Mvs VTGN
PHIOPhio Pharmaceuticals Corp.0.9731-2.69%$11.30Mvs VTGN
ADILAdial Pharmaceuticals Inc3.97-0.50%$10.42Mvs VTGN
TOVXTheriva Biologics Inc.0.2271-2.95%$10.42Mvs VTGN

Related